CME/CE
Popular
- CME/CE
Breaking New Ground: Acoramidis Reduces AF Events in ATTR CM Patients from ESC Heart Failure 2025
Kevin Alexander, MD
Raman Sankar, MD, PhD
Scott Aaronson, MD
Raman Sankar, MD, PhD
Scott Aaronson, MD
Raman Sankar, MD, PhD
Scott Aaronson, MD
Cynthia J. Bither, ACNP-BC, MSN
Andrea Wallace, MSN, FNP-C, HF-Cert
Robert J. Mentz, MD, FHFSA, FACC, FAHA
Piotr Ponikowski, MD, PhD, FESC, FHFA
Kenneth Lieberman, MD
Howard Trachtman, MD, FASN
Jacob Abraham, MD
Bernhard Hellmich, MD
Andreas Kronbichler, MD
- MinuteCE®
Decoding ANCA-Associated Vasculitis (AAV): From Suspicion to Solution
0.75 credits 6 episodesBernhard Hellmich, MD
Andreas Kronbichler, MD
Silke R. Brix, MD, MRCP, SCPR
Matthew R. Weir, MD
Nihar Desai, MD
Ellie Kelepouris, MD, FACP, FAHA
Andreas Kronbichler, MD
Bernhard Hellmich, MD
Bernhard Hellmich, MD
Silke R. Brix, MD, MRCP, SCPR
- CME/CE
Beyond the Broadcast: Expert Insights on SGLT2 Inhibitors in Cardiometabolic Care
0.25 creditsMelissa Magwire, RN, MSN, CDE
Matthew Bullington, PharmD
Dawn M. Denicola, FNP-C
Keith Miller, MD
Kieran McCafferty, MD
Maurizio Gallieni, MD
- CME/CE Broadcast Replay
Refining Strategies for Enhancing Cardiorenal Outcomes With SGLT2 Inhibitors: Optimizing the Cardiometabolic Care Model
1.00 creditMelissa Magwire, RN, MSN, CDE
Matthew Bullington, PharmD
Dawn M. Denicola, FNP-C
Keith Miller, MD
